Patrick Joseph Commerford

Suggest Changes
Learn More
BACKGROUND Patients with atrial fibrillation who are vitamin K antagonist (VKA)-naive may have a higher risk of thrombosis and/or bleeding than VKA-experienced patients. METHODS AND RESULTS Using(More)